Replimune (REPL) Return on Capital Employed [ROCE] (2018 - 2026)
Replimune's Return on Capital Employed [ROCE] was -117.22% in fiscal Q1 2027 (quarter ended Jun 30, 2026), down 51.86 percentage points from -65.36% a year earlier and down 0.78 percentage points from the prior quarter.
Powered by 
Analysis
Replimune (REPL) Return on Capital Employed [ROCE] (2018 - 2026) Analysis & Trends
For FY2026 (ended Mar 31, 2026), Return on Capital Employed [ROCE] at Replimune came in at -83.39%, down 26.16 percentage points from FY2025.
- Return on Capital Employed [ROCE] has now declined for five consecutive fiscal years, with a five-year change of -62.02 percentage points (FY2021 to FY2026).
- In earlier fiscal years, Return on Capital Employed [ROCE] was -57.23% in FY2025 (-12.66 pp), -44.57% in FY2024 (-10.52 pp), -34.05% in FY2023 (-9.47 pp) and -24.58% in FY2022 (-3.20 pp).
- The fiscal Q1 2027 figure marks the lowest quarterly Return on Capital Employed [ROCE] in data going back to fiscal Q1 2019.
- Compared with a year earlier, Return on Capital Employed [ROCE] has declined for 19 straight quarters, with an average year-over-year change of -29.90 percentage points over the last eight quarters.
- The best year-over-year quarter for Return on Capital Employed [ROCE] over five years was fiscal Q2 2022 (a gain of 2.90 percentage points); the worst was fiscal Q4 2026 (a drop of 65.64 percentage points).
- Per Business Quant data, REPL's Return on Capital Employed [ROCE] in the three fiscal quarters before Q1 2027 was -116.44% (Q4 2026), -104.65% (Q3 2026) and -84.99% (Q2 2026).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 17.83% |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 17.92% |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 6.28% |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 19.32% |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 9.54% |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 16.66% |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | -5.97% |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 11.86% |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 20.76% |
| 10 | Replimune | 1.11 Bn | 1.11 Bn | - | -117.22% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -117.22% |
| Mar 31, 2026 | -116.44% |
| Dec 31, 2025 | -104.65% |
| Sep 30, 2025 | -84.99% |
| Jun 30, 2025 | -65.36% |
| Mar 31, 2025 | -50.79% |
| Dec 31, 2024 | -47.92% |
| Sep 30, 2024 | -48.98% |
| Jun 30, 2024 | -49.72% |
| Mar 31, 2024 | -49.96% |
| Dec 31, 2023 | -44.99% |
| Sep 30, 2023 | -39.41% |
| Jun 30, 2023 | -32.35% |
| Mar 31, 2023 | -28.16% |
| Dec 31, 2022 | -29.40% |
| Sep 30, 2022 | -33.98% |
| Jun 30, 2022 | -29.96% |
| Mar 31, 2022 | -26.15% |
| Dec 31, 2021 | -22.79% |
| Sep 30, 2021 | -19.94% |
API Access
Replimune Return on Capital Employed [ROCE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=REPL&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-capital-employed-[roce]", "ticker": "REPL", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=REPL&period=max&api_key=YOUR_API_KEY");
const data = await res.json();